LEUKOTHERA Trademark

Trademark Overview


On Tuesday, February 25, 2020, a trademark application was filed for LEUKOTHERA with the United States Patent and Trademark Office. The USPTO has given the LEUKOTHERA trademark a serial number of 88809129. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Wednesday, December 29, 2021. This trademark is owned by Actinobac Biomed, Inc.. The LEUKOTHERA trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

a protein agent termed leukotoxin derived from a bacterium used in the manufacture of anti-cancer drugs that has specificity for white blood cells

pharmaceutical preparations for the treatment of white blood cell diseases in the form of protein agent termed leukotoxin derived from a bacterium used in the manufacture of anti-cancer drugs that has specificity for white blood cells
leukothera

General Information


Serial Number88809129
Word MarkLEUKOTHERA
Filing DateTuesday, February 25, 2020
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateWednesday, December 29, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 30, 2021

Trademark Statements


Goods and Servicesa protein agent termed leukotoxin derived from a bacterium used in the manufacture of anti-cancer drugs that has specificity for white blood cells
Goods and Servicespharmaceutical preparations for the treatment of white blood cell diseases in the form of protein agent termed leukotoxin derived from a bacterium used in the manufacture of anti-cancer drugs that has specificity for white blood cells
Pseudo MarkLEUKO THERA

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code8 - Abandoned
Class Status DateWednesday, December 29, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, December 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameActinobac Biomed, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKendall Park, NJ 08824

Party NameActinobac Biomed, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKendall Park, NJ 08824

Trademark Events


Event DateEvent Description
Wednesday, December 29, 2021ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Wednesday, December 29, 2021ABANDONMENT - AFTER INTER PARTES DECISION
Wednesday, December 29, 2021OPPOSITION TERMINATED NO. 999999
Wednesday, December 29, 2021OPPOSITION SUSTAINED NO. 999999
Friday, September 24, 2021OPPOSITION INSTITUTED NO. 999999
Friday, April 23, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 30, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 24, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 23, 2021ASSIGNED TO LIE
Friday, November 20, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 20, 2020NON-FINAL ACTION E-MAILED
Wednesday, May 20, 2020NON-FINAL ACTION WRITTEN
Thursday, May 14, 2020ASSIGNED TO EXAMINER
Friday, February 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 28, 2020NEW APPLICATION ENTERED IN TRAM